Belite Bio, Inc

Healthcare

NASDAQ:BLTE · NASDAQ Capital Market

Market Cap $5.54B Beta -1.24 P/E (TTM) -61.0

$138.16 +0.96%

+$1.31 today

52W Low $56.10High $200.00

Vol 0.15M · Avg 0.17M

EPS (TTM)-$2.26

Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+132.01%

Period High

$190.30

Period Low

$56.81

Latest

$138.16

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Praxis Precision Medicines, Inc.

NASDAQ:PRAX

$5.64B

Ligand Pharmaceuticals Incorporated

NASDAQ:LGND

$5.12B

Mirum Pharmaceuticals, Inc.

NASDAQ:MIRM

$4.99B

Crinetics Pharmaceuticals, Inc.

NASDAQ:CRNX

$3.63B

ACADIA Pharmaceuticals Inc.

NASDAQ:ACAD

$3.61B

Viking Therapeutics, Inc.

NASDAQ:VKTX

$3.34B

Arcutis Biotherapeutics, Inc.

NASDAQ:ARQT

$3.05B

Dyne Therapeutics, Inc.

NASDAQ:DYN

$3.01B

Soleno Therapeutics, Inc.

SLNO

$2.76B

ADMA Biologics, Inc.

NASDAQ:ADMA

$1.90B

What is the latest BLTE filing?

The latest filing shown is 6-K dated May 20, 2026.

How many recent filings does BLTE have?

Intrinsic Alpha currently shows 20 recent filings for BLTE.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.